Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France
Journal article published in 2018 by
Christophe Chaignot,
Mahmoud Zureik,
Grégoire Rey,
Rosemary Dray-Spira 
,
Joël Coste,
Alain Weill
,
Joël Coste,
Alain Weill
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 